Simona Mura

Full professor

Université Paris-Saclay

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Simona Mura is a Full Professor at the University of Paris-Saclay in France. Her research encompasses the development of nanomedicine for cancer therapy and inflammatory diseases, focusing on multidimensional tumor models and innovative drug delivery systems. Her recent work includes exploring the role of tumor-associated macrophages, validating in vitro skin irritation tests, and advancing druggable plasma membrane lipid bilayers for targeted medication. Professor Mura’s contributions are vital in the fields of nanotechnology and biomedical research.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

Almar AL ASSAAD

Temporary Teaching and Research Associate

Université de Reims Champagne-Ardenne

FRANCE

View details

Grégory Pieters

FRANCE

View details

Sébastien Mériaux

Research director, head of CIEL (Cerebral Imaging and Engineering Laboratory)

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Simona Mura

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A gold nanocluster/MIL-100(Fe) bimodal nanovector for the therapy of inflammatory disease through attenuation of Toll-like receptor signaling

Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC

Validation study for in vitro skin irritation test using reconstructed human skin equivalents constructed by layer‐by‐layer cell coating technology

Hierarchical superparamagnetic metal–organic framework nanovectors as anti-inflammatory nanomedicines

Plasma membrane lipid bilayer is druggable: Selective delivery of gemcitabine-squalene nano-medicine to cancer cells

Fabrication of high aspect ratio microfluidic devices for long term in vitro culture of 3D tumor models

Breaking photoswitch activation depth limit using ionising radiation stimuli adapted to clinical application

Before in vivo studies: In vitro screening of sphingomyelin nanosystems using a relevant 3D multicellular pancreatic tumor spheroid model

Gemcitabine lipid prodrug nanoparticles: Switching the lipid moiety and changing the fate in the bloodstream.

Investigation of squalene-doxorubicin distribution and interactions within single cancer cell using Raman microspectroscopy

Collaborators (3)

Almar AL ASSAAD

Grégory Pieters

Sébastien Mériaux

Make your next move.